Who Paid My Doc
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Pharmacodynamic Effects of MEDI0382 in Obese Subjects With Non-alcoholic Fatty Liver Disease (NAFLD)/Non-alcoholic Steatohepatitis (NASH)
Research payments
$4,724,902
Through program year 2024, $4,724,902 in research payments was reported against A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Pharmacodynamic Effects of MEDI0382 in Obese Subjects With Non-alcoholic Fatty Liver Disease (NAFLD)/Non-alcoholic Steatohepatitis (NASH), across 98 payments, paid by AstraZeneca Pharmaceuticals LP.
- Paid by
- AstraZeneca Pharmaceuticals LP
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $1,850 | 1 |
| 2022 | Research | $426,193 | 11 |
| 2021 | Research | $1,254,130 | 39 |
| 2020 | Research | $3,006,609 | 44 |
| 2019 | Research | $36,120 | 3 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
8 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Rohit Loomba La Jolla, CA Named on 6 payments
- Grisell Ortiz Rio Piedras, PR Named on 4 payments
- Jeffrey Wayne Lincoln, CA Named on 3 payments
- Charles Andrews San Antonio, TX Named on 2 payments
- Eric Lawitz San Antonio, TX Named on 2 payments
- Yaneicy Gonzalez Rojas Miami, FL Named on 2 payments
- Rogelio MacHuca Las Vegas, NV Named on 2 payments
- John McGettigan Tucson, AZ Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.